News and Insights
The latest news and insights from Genoa Healthcare.
- Behavioral Health
- Clinical Insights
- Partnering with Genoa
CMS reporting now required: 4 ways Genoa can help
By Reena Neumann, PharmD, MBA Since January 1, 2024, the Centers for Medicare & Medicaid Services (CMS) has required that clinics provide outcomes data reporting to secure federal funding through...
- Jan 15th, 2025
- Behavioral Health
- Clinical Insights
- Treatment
Brixadi®: 3 things to know about the buprenorphine treatment option
Staying on top of new medication therapy options for your consumers living with opioid use disorder (OUD) can be difficult. Learn how the new FDA-approved medication, Brixadi®, can help support...
- Oct 30th, 2024
- Behavioral Health
- Consumer Stories
- People-first Pharmacy Care
Genoa Healthcare® Director of Operations featured in Chain Drug Review’s “Excellence in Pharmacy Practice” profile series
Alicia Garcia Afa, PharmD, RPh, a Genoa Healthcare director of pharmacy operations and previous pharmacist who recently helped a consumer navigate a mental health crisis, was featured in Chain Drug Review’s pharmacy...
- Oct 23rd, 2024
- Behavioral Health
- Clinical Insights
- Treatment
Drug trends in behavioral health: What you need to know
Genoa Healthcare recently hosted a webinar where Pharmaceutical Program Manager Allie Butler, PharmD, and Clinical Pharmacist Cameron Yenney, PharmD, discussed the latest drug trends in behavioral health. Watch the recording...
- Oct 11th, 2024
- Behavioral Health
- Clinical Insights
- Treatment
Cobenfy™: 5 things to know about the new schizophrenia treatment option
Staying on top of new medication therapy options for your consumers living with schizophrenia can be difficult. Learn how the new FDA-approved medication, Cobenfy – approved on September 26, 2024...
- Oct 1st, 2024
- Behavioral Health
- Clinical Insights
A discussion with clinic leaders: Standing out in the world of whole-person care
Genoa Healthcare recently hosted a panel-style webinar with leaders from Terros Health, CPC Integrated Health and Southwestern Pennsylvania Human Services, Inc. to discuss how consumers benefit from whole-person care, tips...
- Jun 27th, 2024
- Behavioral Health
- Clinical Insights
- Treatment
Understanding Tardive Dyskinesia: What you need to know
Tardive Dyskinesia (TD) – a neurological disorder associated with prolonged use of antipsychotic medications – affects over 600,000 people annually. Wondering what this means for the people you serve? Genoa...
- Apr 11th, 2024
- Behavioral Health
- Clinical Insights
- Treatment
March 2024 drug trend report
Staying on top of new drug launches and shortages can be difficult. Read Genoa Healthcare’s latest drug trend report for an overview and connect with your local pharmacy team to...
- Mar 13th, 2024
- Behavioral Health
- Clinical Insights
- Treatment
February 2024 drug trend report
Staying on top of new drug launches and shortages can be difficult. Read Genoa Healthcare’s latest drug trend report for an overview and connect with your local pharmacy team to...
- Feb 1st, 2024
- Behavioral Health
- Clinical Insights
- Treatment
Uzedy™: Long-acting injection for the treatment of schizophrenia
Learn more about this new treatment option for adults living with schizophrenia Genoa is here to help keep you informed on the latest in behavioral health medications. Read on to...
- Jan 31st, 2024